Cite
Comparative clinical outcomes of insulin degludec and insulin glargine 300 U/mL after switching from other basal insulins in real-world patients with type 1 and type 2 diabetes.
MLA
Oya, Junko, et al. “Comparative Clinical Outcomes of Insulin Degludec and Insulin Glargine 300 U/ML after Switching from Other Basal Insulins in Real-World Patients with Type 1 and Type 2 Diabetes.” Journal of Diabetes Investigation, vol. 12, no. 11, Nov. 2021, pp. 1983–91. EBSCOhost, https://doi.org/10.1111/jdi.13559.
APA
Oya, J., Nakagami, T., Hasegawa, Y., Katamine, A., Kondo, Y., & Babazono, T. (2021). Comparative clinical outcomes of insulin degludec and insulin glargine 300 U/mL after switching from other basal insulins in real-world patients with type 1 and type 2 diabetes. Journal of Diabetes Investigation, 12(11), 1983–1991. https://doi.org/10.1111/jdi.13559
Chicago
Oya, Junko, Tomoko Nakagami, Yukiko Hasegawa, Aki Katamine, Yuichiro Kondo, and Tetsuya Babazono. 2021. “Comparative Clinical Outcomes of Insulin Degludec and Insulin Glargine 300 U/ML after Switching from Other Basal Insulins in Real-World Patients with Type 1 and Type 2 Diabetes.” Journal of Diabetes Investigation 12 (11): 1983–91. doi:10.1111/jdi.13559.